Piper Jaffray Upgrades CryoLife To Overweight

Analysts at Piper Jaffray upgraded

from Neutral to Overweight. The price target for CryoLife has been raised from $10 to $15. CryoLife shares have dropped 5.20% over the past 52 weeks, while the S&P 500 index has gained 13.38% in the same period. CryoLife's shares rose 1.07% to close at $10.39 yesterday.